Archived

The document provides a detailed overview of the Higher Education Emergency Relief Fund (HEERF) as discussed in a COGR panel session on June 10, 2021, featuring perspectives from both the U.S. Department of Education and several universities. Rich Williams, representing the Department of Education, outlines the session structure and highlights ongoing discussions surrounding financial compliance a

The document provides a detailed account of federal rules, regulations, and executive orders that were either revoked, paused, or placed under review following the January 20, 2021, Regulatory Freeze Pending Review Presidential Memorandum, issued at the start of the Biden administration. Major actions included the revocation of prior executive orders such as EO 13950, which addressed race and sex

The document provides a detailed overview of federal efforts to address regulatory burden and reform policies related to federally funded research, based on statutory requirements from acts such as the 21st Century Cures Act and the American Innovation and Competitiveness Act (AICA). Key reform areas include the establishment of a Research Policy Board, interagency working groups, harmonization of

The Research Project Support Costs Work Group, co-chaired by James Luther of Duke University and Heather Snyder of the Alzheimer’s Association, has undertaken a two-pronged approach to enhance understanding and management of research funding. The Education subgroup recently organized an educational webinar aimed at funding organizations to clarify aspects of facilities and administrative costs. Bu

Document

The document summarizes a presentation delivered at the October 2017 COGR Meeting in Washington, D.C., focused on exploring alternatives to traditional effort reporting in research administration. Initiated by the National Council of University Research Administrators (NCURA) in January 2016, the Cohort project brought together 90 diverse research institutions to develop and promote model policies

The document provides a detailed overview of ClinicalTrials.gov, emphasizing its role as a public registry and results database for clinical studies involving human participants, encompassing interventional trials, observational studies, and expanded access programs across more than 200 countries. Managed by the National Institutes of Health (NIH), ClinicalTrials.gov facilitates transparency, acco

The Common Rule Summary Table outlines significant revisions to federal regulations governing human subjects research. The final rule, effective from January 19, 2018 (with special provisions for cooperative research effective January 20, 2020), distinguishes between non-identified and identifiable biospecimens, treating identifiable biospecimens and private information equivalently and providing

The document, produced by the Council on Governmental Relations (COGR), provides a comprehensive overview of federal regulatory changes affecting the conduct and management of research under federal grants and contracts since the 1991 imposition of a 26% cap on administrative costs in Facilities and Administrative (F&A) cost recovery. Organized chronologically, it lists significant regulations